MRK Merck & Co
- 129.220
- -0.900-0.69%
- 129.550
- +0.330+0.26%
Merck & Co News
Is Merck (NYSE:MRK) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Express News | NYSE Order Imbalance 151490.0 Shares on Sell Side
Merck Late-stage Data Strengthens Profile of Pneumonia Vaccine Candidate
Jumo Health to Lead a Roundtable Discussion on Authenticity and the Patient Voice at the Annual Health Equity in Clinical Trials Congress
NEW HAVEN, Conn., April 29, 2024 /PRNewswire/ -- Jumo Health—a global provider of age-appropriate, culturally relevant medical education—today announced that Kevin Aniskovich, the Company's President
Express News | Merck: Immune Responses Elicited by V116 Were Superior for Nine Serotypes Included in V116 but Not Ppsv23, as Measured by Opa Gmt Ratios at Day 30
Express News | Merck & Co Inc: V116 Elicited Immune Responses That Were Noninferior Compared to Ppsv23 for 12 Serotypes (or Strains) Common to Both Vaccines
Express News | Merck & Co Inc: V116 Had a Safety Profile Comparable to Ppsv23
Express News | Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
Express News | NYSE Order Imbalance 339858.0 Shares on Sell Side
Merck Is Maintained at Buy by Truist Securities
Merck Is Maintained at Buy by Truist Securities
Express News | Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $143
Merck & Co Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 8.87% Truist Securities $142 → $143 Maintains Buy 04/18/2024 2.78% Cantor Fitzgerald → $135 Rei
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Jefferies Adjusts Merck & Company Price Target to $150 From $145
Merck & Company (MRK) has an average rating of outperform and price targets ranging from $114 to $155, according to analysts polled by Capital IQ. Price: 131.18, Change: +0.46, Percent Change: +0.35
Express News | Merck & Co Inc : Guggenheim Raises Target Price to $146 From $144
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the "Fear" zone on Thursday.U.S. stocks settled lower on Thursday, following
Big Bank Ratings | Damo: Raising Merck's Target Price to $132, Raising 2024 Profit Test
According to a research report published by Morgan Stanley, Merck, with the support of the anti-cancer drug Keytruda, despite negative factors from foreign exchange, achieved another excellent result in the first quarter. The bank raised its 2024 earnings forecast for the company and raised its target price from $128 to $132. It believes that the focus for the rest of the year will be on the Winrevair listing. The initial comments are encouraging. The bank gave Merck a “in sync with the market” rating. According to the report, the new revenue guide is 63.1 billion to 64.3 billion US dollars, while the bank raised its forecast from 64.5 billion to 65 billion US dollars, and the market forecast is 63.9 billion US dollars, including
Express News | Merck & Co Inc : Jefferies Raises Target Price to $150 From $145
Earnings Call Summary | Merck & Co(MRK.US) Q1 2024 Earnings Conference
The following is a summary of the Merck & Co., Inc. (MRK) Q1 2024 Earnings Call Transcript:Financial Performance:Total company revenues for Q1 2024 were $15.8 billion, up 9% or 12% excluding foreign e
Overnight news: Weak GDP and high prices highlight the Fed's plight, Alphabet's earnings exceed expectations, and the ECB Governing Council warns that interest rate cuts are needed
For more global financial information, please go to the 7×24 hour real-time financial news market closing: US stocks closed down, the Dow fell more than 370 points, Meta earnings report and GDP data put pressure on the stock index. Top 20 of the US stock turnover on April 25: Meta stock price fell more than 10%. Its capital expenditure guidelines raised concerns that US oil closed higher on Thursday and fell once after the GDP data was released. Popular Chinese securities rose 3.5%, Pinduoduo fell 1.4%, and the German DAX30 index fell 0.89%, and the macroscopic weak GDP Higher prices highlight the US
Analysis
Price Target
No Data
